Thanks for visiting Scientific Computing World.

You're trying to access an editorial feature that is only available to logged in, registered users of Scientific Computing World. Registering is completely free, so why not sign up with us?

By registering, as well as being able to browse all content on the site without further interruption, you'll also have the option to receive our magazine (multiple times a year) and our email newsletters.

Dotmatics chosen for Brazilian research initiative

Share this on social media:

A medicinal chemistry team in Brazil is to accelerate its research using Dotmatics’ data management and analysis solutions.

The company announced that, after careful consideration, the Medicinal Chemistry Team from the University of São Paulo (USP), Brazil, has selected the Dotmatics Platform as its data management system. The team is led by Flavio da Silva Emery, a South American authority on the medicinal chemistry of natural products.

'Medicinal chemistry is a fast-moving area. We are focused on rapidly advancing our research whilst following all of the correct legal requirements to conform to Brazilian and worldwide pharmaceutical standards. After exhaustive evaluation, we concluded that the Dotmatics Platform will fulfil our current and future requirements,' said Dr da Silva Emery. 'We are positive that we will save considerable time and money by avoiding the repetition of experiments.'

Dotmatics says the platform will enable Dr da Silva Emery’s group to keep a detailed register of the natural compounds harvested from several Brazilian biomes as well as the novel compounds synthesised in Ribeirão Preto. The deployment of Studies Notebook will facilitate the recording of research results and ease the continuity of research projects across generations of students and researchers.

The system’s main benefits include the ability to search through experiment results going back several years as well as revealing multiple data types in a single view. This data can then be used to perform complex analysis and pick leads that can be further developed into new drugs.